ID
34656
Beschrijving
Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT01441973
Link
https://clinicaltrials.gov/show/NCT01441973
Trefwoorden
Versies (1)
- 22-01-19 22-01-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
22 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Smoldering Multiple Myeloma NCT01441973
Eligibility Smoldering Multiple Myeloma NCT01441973
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Multiple Myeloma
Datatype
boolean
Alias
- UMLS CUI [1]
- C0026764
Beschrijving
Monoclonal Gammopathy of Undetermined Significance
Datatype
boolean
Alias
- UMLS CUI [1]
- C0026470
Beschrijving
Leukemia, Plasma Cell
Datatype
boolean
Alias
- UMLS CUI [1]
- C0023484
Beschrijving
Hepatitis B positive | Hepatitis C positive | HIV Seropositivity
Datatype
boolean
Alias
- UMLS CUI [1]
- C0856706
- UMLS CUI [2]
- C1112419
- UMLS CUI [3]
- C0019699
Similar models
Eligibility Smoldering Multiple Myeloma NCT01441973
- StudyEvent: Eligibility
C0242485 (UMLS CUI [1,2])
C2238293 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0242485 (UMLS CUI [1,2])
C2238293 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C2826181 (UMLS CUI [3])
C0042037 (UMLS CUI [1,2])
C2238293 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C3274398 (UMLS CUI [3])
C1112419 (UMLS CUI [2])
C0019699 (UMLS CUI [3])